http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP003787-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-02 |
filingDate | 2000-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2562bec2962790e5ee2968f0e909757a |
publicationDate | 2002-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EC-SP003787-A |
titleOfInvention | A PIRAZOLOTRIAZINE REPLACED AS SELECTIVE INVESTED AGONISTS FOR THE GABA-A ALFA5 RECEPTOR SUBTIPE |
abstract | 3-Tere-butyl-7- (5-methylisoxazol-3-yl) -2- (2-methyl-2H- [1.2.4] triazol-3-ylmethoxy) pyrazolo [1,5-d] [1.2 are described .4] triazine, pharmaceutical compositions that comprise them, is used to stimulate cognition and in treatment procedures for subjects suffering from reduced cognition. |
priorityDate | 1999-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70292631 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447979997 |
Total number of triples: 13.